State PA
Clinical Trials in Pennsylvania
Recruiting clinical trials with at least one study location in Pennsylvania. Data updated daily from ClinicalTrials.gov.
Top Conditions in Pennsylvania
Frequently Asked Questions — Clinical Trials in Pennsylvania
How many clinical trials are currently recruiting in Pennsylvania?
ClinicalMetric currently tracks 506 actively recruiting clinical trials with at least one location in Pennsylvania. The total number of registered studies—including active but not currently enrolling trials—is 506. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Pennsylvania?
Pennsylvania hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Opioid Use Disorder, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Pennsylvania serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Pennsylvania?
To join a clinical trial in Pennsylvania, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Pennsylvania maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Pennsylvania
NCT05731141 N/A
Recruiting
A Prospective Natural History Study of Lymphatic Anomalies
Condition
Lymphatic Diseases
Enrollment
1,200 pts
Location
United States
Sponsor
Eunice Kennedy Shriver Nationa
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05410977 N/A
Recruiting
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neopl...
Condition
Colorectal Carcinoma
Enrollment
750 pts
Location
United States
Sponsor
Mayo Clinic
NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
NCT06514794 Phase 2
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-C...
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
125 pts
Location
United States, Australia
Sponsor
Wugen, Inc.
NCT05470205 Phase 3
Recruiting
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewa...
Condition
Liver Diseases
Enrollment
660 pts
Location
United States, Switzerland
Sponsor
Thomas Jefferson University
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in...
Condition
Metastatic Breast Cancer
Enrollment
792 pts
Location
United States, Australia, France
Sponsor
Hoffmann-La Roche
NCT04278651 Phase 4
Recruiting
Early Antenatal Support for Iron Deficiency Anemia
Condition
Pregnancy Related
Enrollment
80 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06819124 N/A
Recruiting
Examining Interactions Between PALS and Caregivers
Condition
Amyotrophic Lateral Sclerosis (ALS)
Enrollment
152 pts
Location
United States
Sponsor
Penn State University
NCT05377905 Phase 1, Phase 2
Recruiting
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
Condition
Cutaneous Squamous Cell Carcinoma
Enrollment
48 pts
Location
United States
Sponsor
Falo, Louis, MD
NCT06162221 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition
Non-Small Cell Lung Cancer, NSCLC
Enrollment
616 pts
Location
United States, Australia, Denmark
Sponsor
Revolution Medicines, Inc.
NCT04899947 N/A
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Condition
Narcolepsy
Enrollment
500 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
NCT05480449 Phase 1, Phase 2
Recruiting
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform fo...
Condition
B Cell Acute Lymphoblastic Leukemia (B-ALL)
Enrollment
89 pts
Location
United States
Sponsor
Stephan Grupp MD PhD
NCT07199764 Phase 2
Recruiting
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Canc...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
100 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06476132 Phase 2
Recruiting
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung...
Condition
Lung Transplant
Enrollment
234 pts
Location
United States, Canada
Sponsor
National Institute of Allergy
NCT05201781 Phase 4
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autole...
Condition
Multiple Myeloma
Enrollment
295 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT06222099 N/A
Recruiting
The HEARTFELT Study
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Heartfelt Technologies
NCT07500506 Phase 3
Recruiting
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth D...
Condition
Lyme Disease
Enrollment
1,712 pts
Location
United States, Canada
Sponsor
Pfizer
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
NCT06306638 Phase 1, Phase 2
Recruiting
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating ...
Condition
Malignant Solid Neoplasm
Enrollment
42 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT03467516 Phase 2
Recruiting
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanom...
Condition
Uveal Neoplasms
Enrollment
47 pts
Location
United States
Sponsor
Udai Kammula
Page 1 of 21 — 506 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology